Phospho-PTEN (Ser380/Thr382/383) Antibody

Skip to product information
1 of 1

Selleck Chemicals

SKU:F0499-20UL

Regular price €159,00 EUR
Regular price Sale price €159,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

PTEN stands out as one of the most commonly deactivated tumor suppressor genes in cancer. Alterations or deficiencies in PTEN gene or protein levels are frequently observed across a wide spectrum of human cancers. Furthermore, inherited syndromes stemming from germline PTEN mutations heighten the risk of tumor development. Depending on the literature source, PTEN may also be discussed as Phospho-PTEN (Ser380/Thr382/383) and Phospho-PTEN (Ser380).

Reported cellular context includes cell projection, cytoplasm, nucleus, and secreted, which can matter when signal is compared across treatments or changing cell states. Following PTEN across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

PTEN is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell projection, cytoplasm, and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cell projection, cytoplasm, and nucleus across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
  • differences between total target abundance and site-specific regulation when modified forms are compared

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for PTEN. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in PTEN reflect biology rather than handling. When interpreting PTEN, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep PTEN trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
PTEN
Research Area:
Cancer • Cell Signaling
Application:
WB
Reactivity:
Human • Monkey • Mouse • Rat
Specificity:
Phospho-PTEN (Ser380/Thr382/383) Antibody [K19C17] detects endogenous levels of PTEN when phosphorylated at Ser380, Thr382 and Thr383. It may also react with PTEN singly phosphorylated at Ser380. The antibody may also detect variants (PTEN-long/PTENα and PTENβ) at 70 kD.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
K19C17
UniProt:
P60484
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.